San Diego, CA, United States of America

Jim Chauvapun

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jim Chauvapun: Pioneering Ultra-Low Volume Liquid Biopsy

Introduction: Jim Chauvapun, an inventive mind based in San Diego, CA, has made significant contributions to the field of medical diagnostics. With a patent under his name, his work focuses on groundbreaking solutions for obtaining genetic information through liquid biopsies, a method poised to transform personal healthcare.

Latest Patents: Chauvapun's prominent patent, titled "Devices, systems and methods for ultra-low volume liquid biopsy," presents innovative devices and kits designed to extract genetic information from cell-free fetal nucleic acids. This pioneering technology facilitates the collection of ultra-low amounts of biological samples, making it possible to perform essential tests at the point of need, significantly enhancing patient convenience and accessibility to vital health information.

Career Highlights: Currently employed at Juno Diagnostics, Inc., Chauvapun is part of a forward-thinking team dedicated to advancing diagnostics technology. His role at Juno Diagnostics emphasizes the importance of innovation in improving clinical practices and patient outcomes, reinforcing his commitment to enhancing the medical field through his inventions.

Collaborations: Throughout his career, Jim has collaborated with notable colleagues in the industry, including Dirk Johannes Van Den Boom and Mathias Ehrich. These partnerships reflect a collective effort towards advancing research and development in liquid biopsy technology, fostering an environment of collaboration and innovation.

Conclusion: Jim Chauvapun stands out as an influential inventor in the realm of medical diagnostics. His singular patent showcases his keen ability to address real-world healthcare challenges through innovative technologies. As he continues to work with Juno Diagnostics and collaborate with other experts, the future of liquid biopsy methods looks promising, with the potential to revolutionize how genetic information is accessed in clinical settings.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…